Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price gain of 2.49% this year. Over the last six months, there has been a weaker performance of 9.21%. The price of BSX leaped by -7.66% during the last 30 days period. For the last 5-days stocks have slided -9.26%.
Boston Scientific Corp experienced a rather steady stock market performance. The highest value in the past year was recorded at $107.17 on 02/05/25 and the lowest value was $66.80 on 04/22/24.
52-week price history of BSX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Boston Scientific Corp’s current trading price is -14.58% away from its 52-week high, while its distance from the 52-week low is 37.04%. The stock’s price range during this period has varied between$66.80 and $107.17. The Boston Scientific Corp’s shares, which operate in the Healthcare, saw a trading volume of around 14.19 million for the day, a figure considerably higher than their average daily volume of 7.6 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Boston Scientific Corp (BSX) has experienced a quarterly rise of 0.94% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 135.39B and boasts a workforce of 53000 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 96.68, with a change in price of +3.29. Similarly, Boston Scientific Corp recorded 6,655,152 in trading volume during the last 100 days, posting a change of +3.73%.
BSX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BSX stands at 0.52. Similarly, the long-term debt-to-equity ratio is also 0.43.
BSX Stock Stochastic Average
Boston Scientific Corp’s raw stochastic average for the past 50 days is presently 26.24%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 30.27%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 25.90% and 40.13%, respectively.
